The 1 analyst offering 1 year price forecasts for APE have a max estimate of — and a min estimate of —.
Analyst rating
Based on 2 analysts giving stock ratings to APE in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
APE EPS for the last quarter is 0.08 CHF despite the estimation of −0.01 CHF. In the next quarter EPS is expected to reach −0.01 CHF. Track more of ADDEX THERAPEUTICS financials and stay on top of what is up with the company.
In the next quarter ADDEX THERAPEUTICS revenue is expected to reach 100.00 K CHF. Check out ADDEX THERAPEUTICS revenue and earnings and make informed decisions.
According to analysts, APE price target is 0.21 CHF with a max estimate of 0.21 CHF and a min estimate of 0.21 CHF. Check if this forecast comes true in a year, meanwhile watch ADDEX THERAPEUTICS stock price chart and keep track of the current situation with APE news and stock market news.